Fytexia’s mission is to reduce risk factors for non-communicable diseases by offering innovative nutritional supplements from our scientific research and inspired by recognised public health food practices.
Fytexia is a life science company expert in scientifically-supported active nutrients for healthcare products.
Fytexia’s team of experts works with a global network of scientific researchers to deliver functional ingredients supported with the most stringent scientific evidence, from the characterization of the active compounds to the demonstration of their clinical benefits. The ingredients developed by Fytexia enter the formulas of the most advanced healthcare products to improve the health and wellbeing of consumers worldwide.
Fytexia operates globally: our health solutions are available in more than 35 countries.
Who we are.
Fytexia was founded in 2003 and is headquartered in the South of France, near Montpellier.
Fytexia develops and manufactures high-value ingredients from a dedicated production site hosting an in-house laboratory for both research and quality control.
Sales and marketing operations are also run from sales offices located in New York, USA and Kuala Lumpur, Malaysia. To provide a global reach, Fytexia serves its customers from EU- or US-based warehouses.
MANUFACTURING ACTIVITY & OFFICES
Fytexia has an integrated team of scientific professionals, including 11 PhDs and MSc, working to develop new ingredients and coordinate international research projects with leading teams, from academic or private institutions.
Fytexia invests yearly 15% of its turnover in scientific research to innovate and demonstrate the health benefits of its selected active compounds.
The ingredients developed by Fytexia are supported with proof of efficacy answering the requirements of the most stringent health authorities.
Focus on research.
Fytexia leads the research and scientific validation of bioactive compounds to deliver turnkey solutions for the improvement of human health and wellbeing through the prevention of non-communicable diseases.
New development programs always start with strong characterization and pharmacokinetic assessments of the selected micronutrients Fytexia qualifies to enter its pipeline of innovation. The validity of the ingredients developed by Fytexia is then supported with proof of efficacy and safety.
Fytexia collaborates with an independent network of academic and private partners to develop protocols for scientific investigations according to gold-standard methodologies.
Feasability & wide-
At Fytexia, the pipeline of product development always takes into consideration the final use of ingredients to fit both market needs and the regulatory environment developers are facing when formulating and offering finished product.
A WORDLWIDE NETWORK OF SCIENTIFIC PARTNERS
SUPPORT SHARED WITH OUR CUSTOMERS
Development & scientific expertise
Marketing & communication
An international reach.
AUSTRALIA – AUSTRIA – BELGIUM – BRAZIL – BULGARIA – CANADA – CHILE – CHINA – CZECH REPUBLIC – ENGLAND – FINLAND – FRANCE – GERMANY – HUNGARY – INDIA –INDONESIA – ITALY – JAPAN – LEBANON – MALAYSIA – MEXICO – NETHERLANDS – PERU – PHILIPPINES – POLAND – PORTUGAL – SERBIA – SINGAPORE – SLOVENIA – SOUTH AFRICA – SOUTH KOREA – SPAIN – SWITZERLAND – TAIWAN – THAILAND – UNITED STATES – VIETNAM